Pharmacogenomics & Pharmacoepidemiology

Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugsPharmacoepidemiology includes pharmacology and epidemiology. Pharmacoepidemiology  a bridges the gap between pharmacology and epidemiology. Epidemiology deals with causes and effects of health & Disease conditions.

  • Translational Pharmacogenomics
  • Applications of NGS to Pharmacogenomics
  • Nutrigenomics
  • Toxicogenomics, Pharmacoproteomics
  • Biomarker Translation and Testing
  • Cancer Pharmacogenomics
  • Pharmacogenitics & Individualized Therapy
  • Pharmacogenomics in Clinical Therapeutics

Related Conference of Pharmacogenomics & Pharmacoepidemiology

January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France

Pharmacogenomics & Pharmacoepidemiology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in